The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Latham & Watkins LLP

555 ELEVENTH STREET, NW, SUITE 1000, WASHINGTON DC 20004-1304, USA
Tel:
Work +1 202 637 2200
Fax:
Fax +1 202 637 2201
Web:
www.lw.com

Maximilian Grant

Tel:
Work +1.212.906.1325
Email:
Web:
www.lw.com
Latham & Watkins LLP

Position

Max Grant serves as trial counsel in patent infringement cases and provides strategic business counseling on intellectual property issues. He led Latham & Watkins’ Intellectual Property Litigation Practice from 2009-2014, a period during which the group more than doubled in size and won the Chambers USA Award for Excellence. The group’s strategic development and unique trial capabilities were featured in an article in The Recorder, an ALM publication. Mr. Grant has tried over 20 patent cases and is recognized as an experienced and innovative first chair trial lawyer.

Career

http://www.lw.com/people/maximilian-grant


United States: Intellectual property

Patents: litigation (full coverage)

Within: Patents: litigation (full coverage)

Latham & Watkins LLP is rated for its 'deep bench of talent', 'deep litigation expertise', and its 'responsiveness, business acumen, industry knowledge and zealous advocacy'. The group is 'not afraid to take calculated risks' and 'thinks creatively', making it an 'excellent choice' for litigation mandates. Recent standout matters show the practice's wide-ranging sector expertise, including an impressive caseload of pharmaceuticals and life sciences litigation. With expertise in district court and ITC litigation alike, the group recently advised Xperi on several cases brought against Samsung regarding 23 patents covering various technologies, including three suits in the Eastern District of Texas, two in New Jersey and one in Delaware Federal Court, in addition to one case at the ITC. Honda instructed the team to advise on its infringement case against Intellectual Ventures, which is pending in California and at the ITC. Major pharmaceutical highlights including the representation of AbbVie Biotechnology in litigation against Amgen and Boehringer Ingelheim, which involved biosimilar versions of blockbuster drug Humira; against Novartis in a 13-patent case involving Hepatitis C drug patents; and against AstraZeneca over blockbuster breast cancer drug Imbruvica. San Diego's Jennifer Barry, Chicago's David Callahan and Washington DC's Michael Morin direct the practice. The 'tough and tenacious' Maximilian Grant, also based in Washington DC, 'adeptly orchestrates all of the assets on the battlefield, but is always focused on the big picture'. Silicon Valley's Douglas Lumish is 'one of the top litigators in the country'. Also of note, Tara Elliott and counsel Rachel Weiner Cohen joined in Washington DC from WilmerHale. Other clients include Arista Networks, Zimmer Biomet and Alvogen.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to